Flaming the fight against cancer cells: the role of microRNA-93.
Milad AshrafizadehMasoud NajafiReza MohammadinejadTahereh FarkhondehSaeed SamarghandianPublished in: Cancer cell international (2020)
There have been attempts to develop novel anti-tumor drugs in cancer therapy. Although satisfying results have been observed at a consequence of application of chemotherapeutic agents, the cancer cells are capable of making resistance into these agents. This has forced scientists into genetic manipulation as genetic alterations are responsible for generation of a high number of cancer cells. MicroRNAs (miRs) are endogenous, short non-coding RNAs that affect target genes at the post-transcriptional level. Increasing evidence reveals the potential role of miRs in regulation of biological processes including angiogenesis, metabolism, cell proliferation, cell division, and cell differentiation. Abnormal expression of miRs is associated with development of a number of pathologic events, particularly cancer. MiR-93 plays a significant role in both physiological and pathological mechanisms. At the present review, we show how this miR dually affects the proliferation and invasion of cancer cells. Besides, we elucidate the oncogenesis or oncosuppressor function of miR-93.
Keyphrases
- cell proliferation
- long non coding rna
- genome wide
- long noncoding rna
- cancer therapy
- poor prognosis
- cell cycle
- papillary thyroid
- gene expression
- pi k akt
- single cell
- drug delivery
- copy number
- cell therapy
- neoadjuvant chemotherapy
- transcription factor
- risk assessment
- climate change
- young adults
- lymph node
- vascular endothelial growth factor
- binding protein
- drug induced
- human health
- heat shock